Skip to main content

Want a detailed portfolio tracker?

DBV Technologies (DBVT) P/E (2021 - 2026)

DBV Technologies (DBVT) P/E from Jun 30, 2021 to Jul 20, 2026. The TTM DBV Technologies (DBVT) P/E is -3.24. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of DBV Technologies (DBVT)

YearP/EChange
2026-3.24-15.31%
2025-3.83+593.46%
2024-0.55-75.83%
2023-2.28-4.85%
2022-2.40-25.30%
2021-3.21N/A

Comparison DBV Technologies (DBVT) P/E with competitors

DBV Technologies (DBVT) P/E is -3.24.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.05%
NBYStablecoin Development Corp0.00-100.13%
ENLVEnlivex Ltd0.07-102.31%
FGENFibroGen Inc0.24-107.40%
CHRSCoherus Biosciences Inc0.85-126.17%
FBIOFortress Biotech Inc0.95-129.27%
ORMPOramed Pharmaceuticals Inc1.50-146.35%
AGENAgenus Inc3.01-192.81%
INVAInnoviva Inc3.15-197.27%
VXRTVaxart Inc3.55-209.47%
CRMDCorMedix Inc3.63-211.90%
CVACCureVac N.V.4.45-237.10%
GLPGGalapagos NV4.86-249.84%
SRPTSarepta Therapeutics Inc4.88-250.56%
ABEOAbeona Therapeutics Inc5.39-266.15%
ABUSArbutus Biopharma Corp5.60-272.57%
ZVRAZevra Therapeutics Inc5.89-281.56%
SPROSpero Therapeutics Inc6.23-292.08%
CGENCompugen Ltd6.31-294.72%
RIGLRigel Pharmaceuticals6.87-311.93%
SLXNSilexion Therapeutics Corp7.30-325.01%
OMEROmeros Corporation9.26-385.53%
AUPHAurinia Pharmaceuticals Inc9.58-395.59%
PLXProtalix BioTherapeutics Inc10.89-435.87%
ACADAcadia Pharmaceuticals Inc11.73-461.70%
TBPHTheravance Biopharma Inc12.26-478.16%
ADMAAdma Biologics Inc12.42-482.97%
HRMYHarmony Biosciences Holdings Inc13.82-526.21%
SABSSAB Biotherapeutics Inc14.14-535.95%
NAGENiagen Bioscience Inc14.82-556.98%
INCYIncyte Corp15.82-587.96%
REGNRegeneron Pharmaceuticals Inc15.86-589.01%
PBYIPuma Biotechnology Inc17.32-634.01%
CPRXCatalyst Pharmaceuticals Inc17.44-637.82%
EXELExelixis Inc17.54-640.86%
TGTXTG Therapeutics Inc18.97-684.90%
MDXGMimedx Group Inc20.55-733.83%
XOMAXOMA Royalty Corp22.87-805.46%
ARGXArgen X SE24.30-849.36%
CTMXCytomX Therapeutics Inc24.82-865.49%
XOMAOXOMA Royalty Corp25.34-881.64%
HALOHalozyme Therapeutics Inc25.62-890.24%
XOMAPXOMA Royalty Corp25.67-891.67%
VRTXVertex Pharmaceuticals Inc27.99-963.36%
RPRXRoyalty Pharma plc - Class A28.69-984.73%
SLNOSoleno Therapeutics Inc29.02-994.84%
ASNDAscendis Pharma A/S30.09-1027.85%
LGNDLigand Pharmaceuticals Inc - Class B37.91-1269.22%
APLSApellis Pharmaceuticals Inc39.02-1303.42%
BMRNBiomarin Pharmaceutical Inc42.21-1401.82%
KRYSKrystal Biotech Inc45.34-1498.40%
ONCBeiGene Ltd69.54-2244.65%
PHARPharming Group N.V.75.03-2413.81%
TECHBio-Techne Corp101.96-3244.42%
VCELVericel Corp109.92-3490.00%
ALNYAlnylam Pharmaceuticals Inc117.96-3738.08%
GMABGenmab140.29-4426.61%
TLXTelix Pharmaceuticals Ltd162.15-5100.84%
CORTCorcept Therapeutics Inc212.86-6664.59%